Table 3

Age and sex specific prevalence

Age		Women			Men			All
Age		Population	No		Prevalence^3-150	Population		No	Prevalence^3-150	Population	No	Prevalence^3-150
0–9	514449	2	3.88	546099	3	5.49	1060548	5	4.71
10–19	686080	13	18.94	725767	8	11.02	1411847	21	14.87
20–29	784094	76	96.92	810345	15	18.51	1594439	91	57.07
30–39	755499	73	96.62	752233	24	31.90	1507732	97	64.33
40–49	680624	68	99.90	682823	25	36.61	1363447	93	68.20
50–59	625513	58	92.72	600974	40	66.55	1226487	98	79.90
60–69	641252	74	115.39	581046	70	120.47	1222298	144	117.81
⩾70	619675	69	111.34	469405	122	259.90	1089081	191	175.37
Total	5307186	433	81.58 (± 9.03)^3-151	5168692	307	59.39 (± 7.70)^3-151	10475878	740	70.63 (± 8.40)^3-151

↵3-150 Prevalence rates are expressed as myasthenia gravis patients/million population.
↵3-151 95% confidence intervals.